Trial
NCT05959421
Immunity Induced by VSV-EBOV and Assessment of a Booster Dose in Individuals at Potential Occupational Risk for Exposure
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Collaborators
Bernhard Nocht Institute for Tropical Medicine; Goethe University; German Federal Ministry of Education and Research; Monipol Deutschland GmbH
Condition
Ebola Vaccine
Intervention
ERVEBO® (rVSV∆G-ZEBOV-GP)
Why stopped
Public funding was withdrawn before the start of the clinical trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-04